Literature DB >> 32350893

Fetal brain, head, and neck tumors: Prenatal imaging and management.

Tamara Feygin1, Nahla Khalek2, Julie S Moldenhauer2.   

Abstract

Fetal tumors represent an infrequent pathology when compared to congenital malformations, although their true incidence may be underestimated. A variety of benign and malignant neoplasms may occur anywhere in the neural axis. Imaging plays an important role in the fetal tumor diagnosis and evaluation of their resultant complications. Discovery of a fetal mass on obstetric ultrasound necessitates further evaluation with prenatal magnetic resonance imaging (MRI). New MR sequences and new applications of existing techniques have been successfully implemented in prenatal imaging. A detailed assessment may be performed using a variety of MR. Fetal tumors may be histologically benign or malignant, but their prognosis generally remains poor, especially for intracranial lesions. Unfavorable tumor location or heightened metabolic demands on a developing fetus may result in severe complications and a fatal outcome, even in cases of benign lesions. Nowadays, prenatal treatment focuses mainly on alleviation of secondary complications caused by the tumors. In this article we review congenital tumors of the brain, face, and neck encountered in prenatal life, and discuss diagnostic clues for appropriate diagnosis.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Year:  2020        PMID: 32350893     DOI: 10.1002/pd.5722

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  2 in total

Review 1.  Fetal Neuroimaging Updates.

Authors:  Jeffrey N Stout; M Alejandra Bedoya; P Ellen Grant; Judy A Estroff
Journal:  Magn Reson Imaging Clin N Am       Date:  2021-11       Impact factor: 2.266

2.  Case report: Ultrasound-guided intrauterine biopsy and RF ablation therapy for fetal posterior neck solid tumor: first successful report.

Authors:  Shanshan Liu; Qiong Luo; Xiaofeng Fu; Minyan Wang; Qingguo Zou; Licheng Wang; Guangjuan Kan; Xing Si; Heqin Dong; Xiani Lan; Yutian Han; Jiang Zhu
Journal:  Front Oncol       Date:  2022-08-23       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.